Estimates: Nirsevimab 89% Effective Against RSV in Kids, 93% Against Hospitalization

• 2024

  Log in to bookmark this resource.

  Log in
• Mary Van Beusekom

---

Access Resources

• SummaryEN
• Ask aRCie About This Resource

About

This news brief describes the effectiveness of nirsevimab, a monoclonal antibody drug, in protecting children under 5 from RSV. The drug is 89% effective against RSV infections and 93% against hospitalizations. A study compared data from the 2023-24 season with earlier years and found similar hospitalization rates. It also mentions an amoxicillin shortage leading to more use of broad-spectrum antibiotics in kids, raising concerns about antibiotic resistance. Additionally, it covers an unexplained outbreak in the Democratic Republic of Congo and rising mpox cases in Africa, with Japan sending vaccines to help control mpox spread among young children.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stages: Response; Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Case-Control Studies; Drug Resistance, Microbial; Hospitalization; Respiratory Syncytial Virus Infections

Institutions: University of Minnesota

---

More like this

Studies Show More Promising Results for RSV Drug Nirsevimab 2024 · University of Minnesota Extending the Reach of Pediatric Emergency Preparedness: A Virtual Tabletop Exercise Targeting Children’s Needs 2019 · Centers for Disease Control and Prevention (CDC), University of Minnesota, University of Southern California Surge Capacity Principles: Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement 2014 · University of Minnesota, The Hebrew University of Jerusalem, George Washington University, University of British Columbia, Sharp Healthcare, Allina Health Care

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---